Clinical Trials Logo

Filter by:
NCT ID: NCT03777436 Completed - Psoriasis Clinical Trials

An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis

DISCREET
Start date: February 11, 2019
Phase: Phase 3
Study type: Interventional

This Phase 3 multicenter, randomized, placebo-controlled, double-blind study is designed to evaluate the efficacy and safety of apremilast in subjects with moderate to severe genital psoriasis (modified sPGA-G ≥3, moderate or severe). Approximately 286 subjects with moderate to severe genital psoriasis will be randomized 1:1 to receive either apremilast 30 mg BID or placebo for the first 16 weeks.

NCT ID: NCT03777072 Recruiting - Pain, Postoperative Clinical Trials

New App for Monitoring Postoperative Pain in Total Ankle Replacement

Start date: December 12, 2018
Phase:
Study type: Observational

The study evaluates a novel web-based application for monitoring the postoperative pain in patients undergoing total ankle replacement, from preoperative condition to 30 days follow-up. The indexes provided by the app in terms of percentages of pain areas are compared with that obtained with traditional visual analogue scale. Moreover, the relation between the percentage of pain area and the presence of side effects of the intervention are compared as well.

NCT ID: NCT03776942 Completed - Clinical trials for Synovial Chondrosarcoma

Synovial Chondrosarcoma: a Single Institution Experience

Start date: August 7, 2018
Phase:
Study type: Observational

single institution cases series review of histological, radiological and clinical data

NCT ID: NCT03776825 Recruiting - Crohn Disease Clinical Trials

Permacol Paste in Perianal Crohn's Disease

UPpCro
Start date: February 7, 2019
Phase:
Study type: Observational

The purpose of this study is to collect data about the efficacy of Permacol Paste treatment in perianal Crohn's Disease.

NCT ID: NCT03776812 Active, not recruiting - Clinical trials for Recurrent Fallopian Tube Carcinoma

Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Start date: January 28, 2019
Phase: Phase 2
Study type: Interventional

This is a Phase 2, open-label, randomized, 3-arm study to evaluate progression-free survival (PFS) in patients with recurrent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer treated with intermittent or continuous regimens of relacorilant in combination with nab-paclitaxel compared with patients treated with nab-paclitaxel alone.

NCT ID: NCT03776396 Completed - Clinical trials for Kidney Transplant; Complications

Perioperative Goal Directed Therapy in Kidney Transplantation

Start date: May 5, 2016
Phase:
Study type: Observational

In literature there is a huge amount of works demonstrating the direct correlation between volemic overload or fluid deficit and hypoperfusion and the increase in the rate of major postoperative complications in patients with high cardiovascular risk and chronic renal failure candidate to kidney transplantation from cadaver. It is also widely demonstrated that in certain populations with high surgical and post-operative complications risk, the adoption of targeted haemodynamic and clinical-therapeutic management protocols is indicated. The current trend is therefore to guarantee greater precision in the intraoperative management of patients undergoing kidney transplantation from cadaver by using a specific protocol that can be framed in the recent and innovative concept of Perioperative Gold Directed Therapy (PGDT), resulting from the adoption of an advanced minimally invasive hemodynamic monitoring technology with a special sensor called FloTrac (Edwards Lifesciences), already extensively tested in an extensive case series of high perioperative risk patients underwent to major abdominal surgery, major vascular surgery, major orthopedic surgery and cardio-thoracic surgery. In the present study there will be enrolled all patients who are candidates for kidney transplant from cadaver at the University Hospital "G. Rodolico" of Catania that meet the inclusion criteria of the study and will give their informed consent to participation. The enrolled patients will be monitored for a maximum period of 7 days from transplantation. As control group there will be considered an historical cohort of patients who underwent kidney transplantation from cadaver in 2015, in which a PGDT protocol was not used, but a common hemodynamic monitoring, based on parameters such as central venous pressure and / or invasive arterial pressure, was performed according to the international guidelines.

NCT ID: NCT03775252 Completed - Migraine Disorders Clinical Trials

A Ketogenic Diet Acts on Cortical But Not Subcortical Responsivity in Migraineurs

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

A short ketogenic diet (KD) treatment can prevent migraine attacks and correct excessive cortical response. Here, investigators aim to prove if the KD-related changes of cortical excitability are primarily due to cerebral cortex activity or are modulated by the brainstem. Through the stimulation of the right supraorbital division of the trigeminal nerve, there will be concurrently interictally recorded the nociceptive blink reflex (nBR) and the pain-related evoked potentials (PREP) in 18 migraineurs patients without aura before and after 1-month on KD, while in metabolic ketosis. nBR and PREP reflect distinct brain structures activation: the brainstem and the cerebral cortex respectively. It will be estimated nBR R2 component area-under-the-curve as well as PREP amplitude habituation as the slope of the linear regression between the 1st and the 2nd block of 5 averaged responses.

NCT ID: NCT03775161 Active, not recruiting - Heart Failure Clinical Trials

V-LAP™ Left Atrium Monitoring systEm for Patients With Chronic sysTOlic & Diastolic Congestive heaRt Failure

VECTOR-HF
Start date: January 8, 2019
Phase: N/A
Study type: Interventional

The purpose of the trial is to evaluate the safety, usability and performance of the V-LAP™ System in adult subjects with New York Heart Association (NYHA) Class III Heart Failure.

NCT ID: NCT03775005 Recruiting - Palliative Care Clinical Trials

Short Course Radiation Therapy in Palliative Treatment of Abdominal Cancer

Start date: November 8, 2017
Phase: N/A
Study type: Interventional

Aim of the study is to assess efficacy of a short course radiation treatment in patients with symptomatic abdominal malignant lesions

NCT ID: NCT03774914 Terminated - Multiple Sclerosis Clinical Trials

LEMTRADA Pregnancy Registry in Multiple Sclerosis

Start date: September 1, 2015
Phase:
Study type: Observational [Patient Registry]

Primary Objective: The primary goal of this registry is to assess the risk of spontaneous abortion in prospective enrolled women exposed to LEMTRADA for multiple sclerosis. Secondary Objective: The secondary goals of this registry is to assess maternal, fetal and infant outcome in women with multiple sclerosis, exposed to LEMTRADA.